MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-07-2025
OptimizeRx Corporation DPO Ratio 2011-2025 | OPRX
Annual DPO Ratio OptimizeRx Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24.1 | 16.8 | 8.71 | 10.6 | 84.1 | 94.1 | 123 | 320 | 316 | 258 | 403 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 403 | 8.71 | 151 |
Quarterly DPO Ratio OptimizeRx Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21.4 | 23.2 | 29.4 | - | 33.3 | 29.8 | 23.7 | - | 10.5 | 16 | 23.2 | - | 18.5 | 17.4 | 9.79 | - | 10.2 | 10.7 | 9.99 | - | 12.5 | 15.5 | 15.6 | - | 22.7 | 16.7 | 26.1 | - | 16.5 | 16.8 | 19.7 | - | - | - | 27.3 | - | - | - | 29.7 | - | - | - | - | - | 21.3 | - | - | - | 32.5 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 33.3 | 9.79 | 20 |
DPO Ratio of other stocks in the Health information services industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Covetrus
CVET
|
41.9 | - | - | $ 2.94 B |  USA |
 |
Cerner Corporation
CERN
|
103 | - | - | $ 27.9 B | USA |
 |
Computer Programs and Systems
CPSI
|
17.8 | - | 4.4 % | $ 133 M | USA |
 |
Accolade
ACCD
|
14.4 | - | 0.29 % | $ 206 M | USA |
 |
Castlight Health, Inc.
CSLT
|
36.1 | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
11.7 | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
115 | - | - | $ 6.37 B | USA |
 |
iCAD
ICAD
|
112 | - | - | $ 102 M | USA |
 |
Evolent Health
EVH
|
27 | $ 4.12 | - | $ 386 M | USA |
 |
Health Catalyst
HCAT
|
19.9 | $ 2.42 | 1.68 % | $ 146 M | USA |
 |
HealthStream
HSTM
|
26.3 | $ 23.61 | - | $ 717 M | USA |
 |
MTBC
MTBC
|
36.4 | - | -0.58 % | $ 51.7 M | USA |
 |
Akerna Corp.
KERN
|
89.4 | - | - | $ 161 M | USA |
 |
HealthEquity
HQY
|
47.8 | $ 93.48 | - | $ 8 B | USA |
 |
Progyny
PGNY
|
171 | $ 25.8 | - | $ 2.21 B | USA |
 |
10x Genomics
TXG
|
32.5 | $ 16.49 | - | $ 1.93 B | USA |
 |
American Well Corporation
AMWL
|
11.6 | $ 4.55 | - | $ 68.2 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
10.9 | - | -10.39 % | $ 886 M | USA |
 |
Schrödinger
SDGR
|
66.5 | $ 18.31 | - | $ 1.33 B | USA |
 |
GoodRx Holdings
GDRX
|
191 | $ 2.75 | - | $ 1.06 B | USA |
 |
Omnicell
OMCL
|
27.6 | $ 46.4 | - | $ 2.14 B | USA |
 |
1Life Healthcare
ONEM
|
18 | - | - | $ 3.37 B | USA |
 |
Phreesia
PHR
|
57.8 | $ 17.02 | - | $ 929 M | USA |
 |
Premier
PINC
|
28.6 | $ 28.26 | - | $ 2.33 B | USA |
 |
R1 RCM
RCM
|
5.63 | - | - | $ 3.81 B | USA |
 |
NantHealth
NH
|
86.1 | - | -46.64 % | $ 10.4 M | USA |
 |
Zhongchao
ZCMD
|
32 | $ 0.51 | - | $ 2.65 M |  China |
 |
NextGen Healthcare
NXGN
|
14.5 | - | - | $ 1.6 B | USA |
 |
Signify Health
SGFY
|
57.5 | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
62 | - | - | $ 21.4 M | USA |
 |
Teladoc Health
TDOC
|
18.6 | $ 7.12 | - | $ 1.21 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
22.2 | - | - | $ 255 M | USA |
 |
Veeva Systems
VEEV
|
19.7 | $ 224.65 | - | $ 36.1 B | USA |
 |
SCWorx Corp.
WORX
|
43.2 | $ 0.21 | - | $ 306 K | USA |